Oncotelic Therapeutics (OTLC) Cash & Current Investments (2010 - 2026)
Oncotelic Therapeutics' Cash & Current Investments came in at $206,014 for Q2 2026, up 90.7% from $108,022 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Oncotelic Therapeutics' Cash & Current Investments was $108,857, up 2.6% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of -26.1% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $106,128 in FY2024 (-44.3%), $190,405 in FY2023 (-27.2%), $261,452 in FY2022 (-55.6%) and $588,769 in FY2021 (+19.2%).
- The five-year range for quarterly Cash & Current Investments is $92,216 (Q2 2024) to $588,769 (Q4 2021).
- Year-over-year, Cash & Current Investments increased in four of the last seven quarters, with growth averaging 18.0%.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q3 2022 (growth of 179.2%), and the weakest in Q3 2021 (a decline of 92.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Oncotelic Therapeutics | 8.05 Mn | 7.20 Mn | - | 206,014.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 206,014.00 |
| Dec 31, 2025 | 108,857.00 |
| Sep 30, 2025 | 429,000.00 |
| Jun 30, 2025 | 108,022.00 |
| Mar 31, 2025 | 99,173.00 |
| Dec 31, 2024 | 106,128.00 |
| Sep 30, 2024 | 169,018.00 |
| Jun 30, 2024 | 92,216.00 |
| Mar 31, 2024 | 208,989.00 |
| Dec 31, 2023 | 190,405.00 |
| Sep 30, 2023 | 288,022.00 |
| Jun 30, 2023 | 201,872.00 |
| Mar 31, 2023 | 210,435.00 |
| Dec 31, 2022 | 261,452.00 |
| Sep 30, 2022 | 273,882.00 |
| Jun 30, 2022 | 419,772.00 |
| Mar 31, 2022 | 117,906.00 |
| Dec 31, 2021 | 588,769.00 |
| Sep 30, 2021 | 98,081.00 |
| Jun 30, 2021 | 481,285.00 |
API Access
Oncotelic Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();